References

Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach

10.1016/j.radonc.2013.05.007 · 2013 · External reference

Paediatric proton therapy

10.1259/bjr.20190601 · 2020 · External reference

Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer

10.1001/jamaoncol.2019.4889 · 2020 · External reference

Proton versus photon radiation therapy: a clinical review

10.3389/fonc.2023.1133909 · 2023 · External reference

Impact of proton versus photon adjuvant radiotherapy on overall survival in the management of skull base and spinal chordomas: a National Cancer Database analysis

2024 · External reference

Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma

10.1200/jco.19.01706 · 2020 · External reference

A systematic review of pediatric neuropsychological outcomes with proton versus photon radiation therapy: a call for equity in access to treatment

10.1017/s1355617722000819 · 2023 · External reference

Risk of secondary malignant neoplasms in children following proton therapy vs photon therapy for primary CNS tumors: a systematic review and meta-analysis

10.3389/fonc.2022.893855 · 2022 · External reference

Secondary neutron dose measurement for proton line scanning therapy

2016 · External reference

Secondary neutrons in clinical proton radiotherapy: a charged issue

10.1016/j.radonc.2007.12.003 · 2008 · External reference

Secondary neutron dose during proton therapy using spot scanning

10.1016/s0360-3016(01)02826-7 · 2002 · External reference

Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age

10.1016/j.ijrobp.2008.04.069 · 2008 · External reference

Proton beam therapy for childhood malignancies: status report

10.1055/s-0030-1249657 · 2010 · External reference

Pencil beam characteristics of the next-generation proton scanning gantry of PSI: design issues and initial commissioning results

10.1140/epjp/i2011-11066-0 · 2011 · External reference

Long-term outcomes and quality of life of children with intracranial ependymoma treated with pencil beam scanning proton therapy

10.1002/pbc.31728 · 2025 · External reference

Evaluation of survival data and two new rank order statistics arising in its consideration

1966 · External reference

Unresolved reference

External reference

The effectiveness and safety of proton beam radiation therapy in children and young adults with central nervous system tumors: a systematic review

10.1007/s11060-023-04510-4 · 2024 · External reference

Pencil beam scanning proton therapy for pediatric intracranial ependymoma

10.1007/s11060-016-2090-4 · 2016 · External reference

Use of proton therapy for re-irradiation in pediatric intracranial ependymoma

10.1016/j.radonc.2015.07.023 · 2015 · External reference

Outcomes following proton therapy for pediatric ependymoma

10.1080/0284186x.2017.1413248 · 2018 · External reference

Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients

10.1093/neuonc/not121 · 2013 · External reference

Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy

10.1002/cncr.30623 · 2017 · External reference

Proton therapy for pediatric ependymoma: mature results from a bicentric study

10.1016/j.ijrobp.2021.01.027 · 2021 · External reference

Incidence of second malignancies among patients treated with proton versus photon radiation

10.1016/j.ijrobp.2013.04.030 · 2013 · External reference

Photon or proton therapy for adolescent and young adult tumors focused on long-term survivors

2021 · External reference

Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy

10.1093/neuonc/noaa139 · 2021 · External reference

Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases

10.1667/rr2629.1 · 2012 · External reference

Solid cancer incidence in atomic bomb survivors: 1958–1998

10.1667/rr0763.1 · 2007 · External reference

Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997

10.1667/rrav12.1 · 2012 · External reference

Cancer risk among atomic bomb survivors: the RERF life span study

10.1001/jama.1990.03450050059028 · 1990 · External reference

Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype

10.1007/s00401-021-02304-4 · 2021 · External reference

Secondary malignancies following cancer chemotherapy

10.3109/02841869409121767 · 1994 · External reference

Review of risk factors of secondary cancers among cancer survivors

10.1259/bjr.20180390 · 2019 · External reference

Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer

10.1016/j.ijrobp.2009.01.040 · 2009 · External reference

Determining out-of-field doses and second cancer risk from proton therapy in young patients: an overview

10.3389/fonc.2022.892078 · 2022 · External reference

The ANDANTE project: a multidisciplinary approach to neutron RBE

10.1093/rpd/ncv158 · 2015 · External reference

Sarcoma arising in irradiated bone: report of 11 cases

10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7 · 1948 · External reference

Autonomous DNA nanostructures instructed by hierarchically concatenated chemical reaction networks

10.1038/s41467-021-25450-5 · 2021 · External reference

Irradiation-induced secondary tumors following pediatric central nervous system tumors: experiences of a single institute in Taiwan (1975–2013)

10.1016/j.ijrobp.2018.04.032 · 2018 · External reference